Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti PD-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06580938
What this trial is testing

Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer

Who this might be right for
Non Small Cell Lung CancerBladder CancerRenal Cell Carcinoma+3 more
Pfizer 4
Not applicableUnknownNCT04743752
What this trial is testing

Obstructive Sleep Apnea Influences Efficacy of PD-1-Based Immunotherapy Against Non-Small Cell Lung Cancer

Who this might be right for
Obstructive Sleep ApneaNon-small Cell Lung Cancer
Peking University First Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06782932
What this trial is testing

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Early research (Phase 1)UnknownNCT06404281
What this trial is testing

Γδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Changzhou No.2 People's Hospital 9
Testing effectiveness (Phase 2)Study completedNCT03453164
What this trial is testing

Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT)

Who this might be right for
Gastric Cancer
Fukushima Medical University 41
Testing effectiveness (Phase 2)UnknownNCT03557411
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Shandong Cancer Hospital and Institute 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT03480334
What this trial is testing

Abscopal Effect of Radiotherapy and Nivolumab in Relapsed Hodgkin Lymphoma After Anti-PD1 Therapy

Who this might be right for
Classical Hodgkin Lymphoma
University of Cologne 26
Not applicableNot Yet RecruitingNCT07376512
What this trial is testing

Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis

Who this might be right for
Non-Small Cell Lung CancerMelanoma (Skin Cancer)
Centre Georges Francois Leclerc 378
Testing effectiveness (Phase 2)Looking for participantsNCT06556199
What this trial is testing

Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma

Who this might be right for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 38
Testing effectiveness (Phase 2)Looking for participantsNCT05039632
What this trial is testing

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the Lung+1 more
M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT03061955
What this trial is testing

Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)

Who this might be right for
Influenza Virus Vaccine Adverse Reaction (Disorder)InfluenzaMalignancy
Wake Forest University Health Sciences 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04214249
What this trial is testing

BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT05525455
What this trial is testing

TT-816 As Monotherapy or in Combination with a PD-1 Inhibitor in Patients with Advanced Cancers (SEABEAM) (MK3475-E88)

Who this might be right for
Advanced CancerAdvanced Solid TumorCancer+1 more
Teon Therapeutics, Inc. 9
Early research (Phase 1)Study completedNCT03475251
What this trial is testing

CS1003 in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
CStone Pharmaceuticals 108
Early research (Phase 1)Ended earlyNCT03144466
What this trial is testing

Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer

Who this might be right for
Cervix Cancer
Royal Marsden NHS Foundation Trust 1
Testing effectiveness (Phase 2)UnknownNCT03972722
What this trial is testing

Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Guangzhou Gloria Biosciences Co., Ltd. 89
Large-scale testing (Phase 3)Looking for participantsNCT07822646
What this trial is testing

Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chinese PLA General Hospital 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04719988
What this trial is testing

Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma.

Who this might be right for
Squamous Cell Carcinoma of the Anus Stage III
Centre Hospitalier Universitaire de Besancon 55
Testing effectiveness (Phase 2)UnknownNCT03811379
What this trial is testing

Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy

Who this might be right for
Small Cell Carcinoma of EsophagusAdvanced Cancer
Sun Yat-sen University 43
Testing effectiveness (Phase 2)Study completedNCT03294083
What this trial is testing

Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
SillaJen, Inc. 95
Next Page
49